Medtronic Reports Q3 Beat & Raises Guidance 
<p><a href='https://financialmodelingprep.com/financial-summary/MDT'>Medtronic (NYSE:MDT)</a> reported its Q3 results, with both EPS of $1.30 and revenue of $7.7 billion coming in better than the Street estimates of $1.27 and $7.54 billion, respectively. </p>
<p>Better-than-expected revenue was driven by beats across all of its business segments, with headwinds abating in ventilator sales and product availability.</p>
<p>The company raised its 2023 guidance, now expecting FX rates to negatively impact Q4 revenue by $165-215 million and guided to 2023 EPS of $5.28-$5.30 (prior guidance of $5.25-5.30), which includes an $0.21 FX headwind as of current rates. </p>
<p>The company continues to expect expense reductions to help offset headwinds e.g. inflation, interest, FX, and taxes. Additionally, the company noted it expects organic growth of 4.5-5.0% in Q4.</p>

NYSE:MDT